These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 11460484)
1. Genetic manipulation of fibrinogen and fibrinolysis in mice. Degen JL; Drew AF; Palumbo JS; Kombrinck KW; Bezerra JA; Danton MJ; Holmbäck K; Suh TT Ann N Y Acad Sci; 2001; 936():276-90. PubMed ID: 11460484 [TBL] [Abstract][Full Text] [Related]
2. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Palumbo JS; Kombrinck KW; Drew AF; Grimes TS; Kiser JH; Degen JL; Bugge TH Blood; 2000 Nov; 96(10):3302-9. PubMed ID: 11071621 [TBL] [Abstract][Full Text] [Related]
3. Genetic interactions between the coagulation and fibrinolytic systems. Degen JL Thromb Haemost; 2001 Jul; 86(1):130-7. PubMed ID: 11486998 [TBL] [Abstract][Full Text] [Related]
4. Role of fibrinogen- and platelet-mediated hemostasis in mouse embryogenesis and reproduction. Palumbo JS; Zogg M; Talmage KE; Degen JL; Weiler H; Isermann BH J Thromb Haemost; 2004 Aug; 2(8):1368-79. PubMed ID: 15304043 [TBL] [Abstract][Full Text] [Related]
5. [From fibrinogen to fibrin and its dissolution]. Juhan-Vague I; Hans M Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455 [TBL] [Abstract][Full Text] [Related]
6. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Palumbo JS; Potter JM; Kaplan LS; Talmage K; Jackson DG; Degen JL Cancer Res; 2002 Dec; 62(23):6966-72. PubMed ID: 12460914 [TBL] [Abstract][Full Text] [Related]
7. Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment? Daly ME; Makris A; Reed M; Lewis CE J Natl Cancer Inst; 2003 Nov; 95(22):1660-73. PubMed ID: 14625257 [TBL] [Abstract][Full Text] [Related]
8. Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense. Prasad JM; Gorkun OV; Raghu H; Thornton S; Mullins ES; Palumbo JS; Ko YP; Höök M; David T; Coughlin SR; Degen JL; Flick MJ Blood; 2015 Oct; 126(17):2047-58. PubMed ID: 26228483 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation. Hoppe B Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841 [TBL] [Abstract][Full Text] [Related]
10. Fibrin and fibrinolysis in infection and host defense. Degen JL; Bugge TH; Goguen JD J Thromb Haemost; 2007 Jul; 5 Suppl 1():24-31. PubMed ID: 17635705 [TBL] [Abstract][Full Text] [Related]